Correlation Between Mammographic Radiomics Features and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00412
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Intrinsic Prognostic Impact of Tumor-Infiltrating Lymphocytes in Systemically Untreated Patients With Early-Stage Triple-Negative Breast Cancer

Anticancer Research
MedicineCancer ResearchOncology
2019English

Prognostic Value of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Multi-Panel Immunofluorescence Analysis of Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer: Evolution of Tumor Immune Profiles and Patient Prognosis

PLoS ONE
Multidisciplinary
2020English

Prognostic Impact of a Tumor-Infiltrating Lymphocyte Subtype in Triple Negative Cancer of the Breast

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2020English

Clinical Significance of Tumor-Infiltrating Lymphocytes in Breast Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2016English

Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas

Frontiers in Immunology
AllergyImmunology
2014English

Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer

Breast Cancer: Basic and Clinical Research
Cancer ResearchOncology
2017English

Tumoral BRD4 Expression in Lymph Node-Negative Breast Cancer: Association With T-Bet+ Tumor-Infiltrating Lymphocytes and Disease-Free Survival

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Distribution of CD4+ and CD8+ Exhausted Tumor-Infiltrating Lymphocytes in Molecular Subtypes of Chinese Breast Cancer Patients

OncoTargets and Therapy
OncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy